Why the study?
Recent data from the STICH trial challenged historical concepts by showing viable myocardium volume failed to predict coronary artery bypass grafting effectiveness, questioning whether viability testing should be abandoned or reinterpreted.
Does myocardial viability testing predict the effectiveness of revascularization in patients with ischaemic left ventricular dysfunction?
Does myocardial viability testing predict the effectiveness of revascularization in patients with ischaemic left ventricular dysfunction?
This review highlights that the traditional model of using myocardial viability testing to guide revascularization is challenged by recent data, suggesting a need for new paradigms.
No takes yet. Share an insight, caveat, or question.
Viability testing should not guide revascularization decisions; leaves open need for new selection paradigms in ischaemic LV dysfunction.
Ryan et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: